{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:07Z","timestamp":1786986907953,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Al-Hayat Pharmaceutical Company"},{"DOI":"10.13039\/501100005712","name":"University of Jordan","doi-asserted-by":"publisher","award":["8\/2014\/2015"],"award-info":[{"award-number":["8\/2014\/2015"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005712","name":"University of Jordan","doi-asserted-by":"publisher","award":["97\/2013\/2014"],"award-info":[{"award-number":["97\/2013\/2014"]}],"id":[{"id":"10.13039\/501100005712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clnu.2020.09.024","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:08:32Z","timestamp":1600978112000},"page":"870-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5738-4402","authenticated-orcid":false,"given":"Nahla","family":"Al-Bayyari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder","family":"Al-Domi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra'ed","family":"Hailat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arieanna","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5653\/cerm.2014.41.2.80","article-title":"Vitamin D deficiency in women with polycystic ovary syndrome","volume":"41","author":"Kim","year":"2014","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"10.1016\/j.clnu.2020.09.024_bib2","first-page":"465","article-title":"The effects of calcitriol on improvement of insulin resistance, ovulation and comparison with metformin therapy in PCOS patients: a randomized placebo-controlled clinical trial","volume":"10","author":"Bonakdaran","year":"2012","journal-title":"Iran J Reprod Med"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society 2009. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the Complete Task Force Report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.024_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the etiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson","year":"2012","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.024_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nutres.2012.02.001","article-title":"Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency","volume":"32","author":"Rahimi-Ardabili","year":"2012","journal-title":"Nutr Res"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.024_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mefs.2012.04.005","article-title":"Effect of 25-hydroxyvitamin D on metabolic parameters and insulin resistance in patients with polycystic ovarian syndrome","volume":"17","author":"Hassan","year":"2012","journal-title":"Middle East Fertil Soc J"},{"issue":"8","key":"10.1016\/j.clnu.2020.09.024_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1089\/jwh.2016.5792","article-title":"Lifestyle and behavioral management of polycystic ovary syndrome","volume":"26","author":"Brennan","year":"2017","journal-title":"J\u00a0women\u2019s Health"},{"key":"10.1016\/j.clnu.2020.09.024_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/cen.13112","article-title":"Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial","volume":"85","author":"Orio","year":"2016","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.clnu.2020.09.024_bib9","first-page":"305","article-title":"Effects of physical exercise on the female reproductive system","volume":"38","author":"Orio","year":"2013","journal-title":"Minerva Endocrinol"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.024_bib10","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"issue":"7\u20138","key":"10.1016\/j.clnu.2020.09.024_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00508-009-1162-2","article-title":"Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome","volume":"121","author":"Wehr","year":"2009","journal-title":"Wien Klin Wochenschr"},{"issue":"10","key":"10.1016\/j.clnu.2020.09.024_bib12","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.metabol.2011.03.002","article-title":"Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome","volume":"60","author":"Li","year":"2011","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.clnu.2020.09.024_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2006-948308","article-title":"Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome","volume":"114","author":"Hahn","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.clnu.2020.09.024_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00404-009-0958-7","article-title":"Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome","volume":"280","author":"Yildizhan","year":"2009","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.fertnstert.2014.04.046","article-title":"Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review","volume":"102","author":"Irani","year":"2014","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.clnu.2020.09.024_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF03345785","article-title":"The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome","volume":"33","author":"Selimoglu","year":"2010","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"10","key":"10.1016\/j.clnu.2020.09.024_bib17","first-page":"757","article-title":"Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in PCOS women-A pilot study","volume":"34","author":"Wehr","year":"2011","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"12","key":"10.1016\/j.clnu.2020.09.024_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/09513590.2012.696753","article-title":"Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome","volume":"28","author":"Pal","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ctcp.2012.01.005","article-title":"Therapeutic effects of calcium and vitamin D supplementation in women with PCOS","volume":"18","author":"Firouzabadi","year":"2012","journal-title":"Compl Ther Clin Pract"},{"key":"10.1016\/j.clnu.2020.09.024_bib20","series-title":"Statistical methods","author":"Snedecor","year":"1980"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.024_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE-ASRM Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4158\/EP.15.2.95","article-title":"Evaluation of vitamin D repletion regimens to correct vitamin D status in adults","volume":"15","author":"Pepper","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clnu.2020.09.024_bib23","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","article-title":"Clinical assessment of body hair growth in women","volume":"21","author":"Ferriman","year":"1961","journal-title":"J\u00a0Clin Endocrinol"},{"key":"10.1016\/j.clnu.2020.09.024_bib24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u0392-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.clnu.2020.09.024_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiology.150.2.6691114","article-title":"Polycystic ovarian disease: sonographic spectrum","volume":"150","author":"Hann","year":"1984","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.024_bib26","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1148\/rg.326125503","article-title":"Polycystic ovarian syndrome: role of imaging in diagnosis","volume":"32","author":"Lee","year":"2012","journal-title":"Radiographics"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.024_bib27","first-page":"1080","article-title":"Transvaginal ultrasound measurement of ovarian volume in PortHarcourt","volume":"2","author":"Nwanko","year":"2011","journal-title":"J\u00a0Med Med Sci"},{"issue":"12","key":"10.1016\/j.clnu.2020.09.024_bib28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American association of clinical endocrinologists, American college of endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome \u2013 part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.024_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ejcn.2012.25","article-title":"Vitamin D status and determinants of deficiency among non-pregnant Jordanian women of reproductive age","volume":"66","author":"Nichols","year":"2012","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.024_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000323097","article-title":"Vitamin D status in Jordan: dress style and gender discrepancies","volume":"58","author":"Batieha","year":"2011","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.clnu.2020.09.024_bib31","first-page":"28","article-title":"Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency","volume":"36","author":"Rahimi-Ardabili","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.024_bib32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.fertnstert.2014.02.021","article-title":"High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial","volume":"101","author":"Khan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.clnu.2020.09.024_bib33","doi-asserted-by":"crossref","first-page":"116940","DOI":"10.1016\/j.lfs.2019.116940","article-title":"Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome","volume":"236","author":"Wang","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.clnu.2020.09.024_bib34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clnu.2011.12.010","article-title":"Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?","volume":"31","author":"Muscogiuri","year":"2012","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2020.09.024_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4274\/tjod.galenos.2019.46244","article-title":"Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome","volume":"16","author":"Behmanesh","year":"2019","journal-title":"Turk J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.clnu.2020.09.024_bib36","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1530\/EJE-11-0134","article-title":"Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome","volume":"164","author":"Wehr","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"10.1016\/j.clnu.2020.09.024_bib37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3390\/nu9121280","article-title":"Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome","volume":"9","author":"Jamilian","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnu.2020.09.024_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.33549\/physiolres.933266","article-title":"The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome-A preliminary study","volume":"65","author":"Dravecka","year":"2016","journal-title":"Physiol Res"},{"issue":"6","key":"10.1016\/j.clnu.2020.09.024_bib39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0039-128X(99)00012-4","article-title":"Vitamin D and calcium dysregulation in the polycystic ovarian syndrome","volume":"64","author":"Thys-Jacobs","year":"1999","journal-title":"Steroids"},{"issue":"9","key":"10.1016\/j.clnu.2020.09.024_bib40","first-page":"875","article-title":"The effect of calcium and vitamin D supplementation on menstrual cycle, body mass index and hyperandrogenism state of women with poly cystic ovarian syndrome","volume":"19","author":"Tehrani","year":"2014","journal-title":"J\u00a0Res Med Sci"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420304969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420304969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:08:39Z","timestamp":1759367319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561420304969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0261561420304969"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.024","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}